» Articles » PMID: 25121791

Flow-diverting Stents for Intracranial Bifurcation Aneurysm Treatment

Overview
Journal Neurosurgery
Specialty Neurosurgery
Date 2014 Aug 15
PMID 25121791
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although initially considered safe when covering bifurcation sites, flow-diverting stents may provoke thrombosis of side branches that are covered during aneurysm treatment.

Objective: To understand the occurrence and clinical expression of side-branch remodeling in distal intracranial arterial sites after flow diverter deployment by means of correlation of imaging and clinical data.

Methods: We analyzed our prospectively collected data on a series of patients treated with flow diverters for intracranial aneurysms at bifurcation sites. From February 2011 to May 2013, 32 patients with 37 aneurysms (anterior communicating artery, 9 [24.3%]; anterior cerebral artery, 5 [13.5%]; middle cerebral artery, 19 (51.4%); terminal internal carotid artery, 4 [10.8%]) were treated. We divided aneurysms into 2 groups based on the side branches covered by the stent during treatment. Group A consisted of cases with side branches that supplied brain territories also receiving a direct collateral supply. Group B consisted of cases in which side branches supplied territories without direct collateral supply. The 2 groups were compared statistically.

Results: Total exclusion occurred in 97.3% of aneurysms at follow-up. Initial modified Rankin Scale (mRS) score was 0 to 1 for 29 patients (90.6%) and 2 for 3 patients (9.4%). New permanent neurological deficit was reported in 3 patients (9.4%). At the 6-month follow-up, the mRS score was 0 to 1 for 31 patients (96.8%) and 3 for 1 patient (3.2%). Although 78.5% of side branches in group A underwent narrowing or occlusion after 6 months, no new stroke was found on magnetic resonance imaging.

Conclusion: Symptomatic modifications of side branches after flow diverter treatment depend on the extent and type of collateral supply.

Citing Articles

Intrasaccular Treatment of Intracranial Aneurysms: A Comprehensive Review.

Shao M, White T, Bassett J, Dowlati E, Mehta S, Werner C J Clin Med. 2024; 13(20).

PMID: 39458111 PMC: 11508718. DOI: 10.3390/jcm13206162.


Flow diversion for unruptured MCA bifurcation aneurysms: comparison of p64 classic, p64 MW HPC, and p48 MW HPC flow diverter stents.

Hellstern V, Brenner N, Cimpoca A, Albina Palmarola P, Henkes E, Wendl C Front Neurol. 2024; 15:1415861.

PMID: 39206292 PMC: 11349692. DOI: 10.3389/fneur.2024.1415861.


Neurological outcomes of flow-diverter stent placement for middle cerebral artery aneurysms, with reference to the effects of argatroban on ischemic events: patient series.

Yoshida S, Kazekawa K, Kamatani K, Maruyama K, Takigawa K, Tashiro N J Neurosurg Case Lessons. 2024; 8(6).

PMID: 39102752 PMC: 11301586. DOI: 10.3171/CASE24237.


Endovascular treatment of intracranial internal carotid artery bifurcation region aneurysms.

Liu X, Guo Y, Zhang K, Yu J Front Neurol. 2024; 15:1344388.

PMID: 38606281 PMC: 11008469. DOI: 10.3389/fneur.2024.1344388.


Risk factor analysis of changes in blood flow in the A1 segment of the anterior cerebral artery after flow-diverter coverage of it.

Ma W, Deng X, Chen J, Guo X Neurosurg Rev. 2024; 47(1):74.

PMID: 38315259 DOI: 10.1007/s10143-024-02306-2.